Although TRPV2 cytoplasmic expression in carcinoma cells varied widely between each ESCC sample, we initially evaluated TRPV2 signal intensities in cancer cells as no, weak, and strong expression (Fig. 4B–D); the proportion of each intensity in tumors was subsequently measured. This evidence concerns the gene TRPV2 and carcinoma.